Valganciclovir dosing in congenital cytomegalovirus infection shows extensive drug accumulation in dried blood spots
New blood test tracks cCMV drug levels in infants
This randomized, placebo-controlled clinical trial (ValEAR) or open-label PK study evaluated infants with congenital cytomegalovirus infecti…
A new blood spot test helps doctors track cCMV medicine levels in babies to prevent dangerous side effects during treatment.
Minnesota implements universal newborn screening and surveillance for congenital cytomegalovirus
Minnesota begins universal newborn screening for congenital cytomegalovirus
A surveillance report describes the implementation of universal newborn screening and population-based surveillance for congenital cytomegal…
Minnesota starts universal newborn screening for a virus that can cause hearing loss or developmental problems if passed from mother to chil…